Joint Transnational Call 2009 – Funded Projects

Joint Transnational Call (JTC2009)

  • CAV-4-MPS: Understanding and treating neurodegeneration caused by mucopolysaccharidoses
  • Cure-FXS: Targeting Rho-signalling, a new therapeutic avenue in fragile X syndrome
  • EB: Identification of revertant mosaicism in epidermolysis bullosa and subsequently using the revertant keratinocytes in a pre-clinical mouse model suitable to test revertant cell therapy
  • ELA2-CN: Congenital neutropenia with ELA-2 mutations (ELA2-CN): Identification of (epi)genetic co-factors and molecular pathways underlying clinical heterogeneity
  • EMINA: European Multidisciplinary Initiative on Neuroacanthocytosis
  • EuPAPNet: European pulmonary alveolar proteinosis network : molecular determinants of causes, variability and outcome
  • EURO-CDG: Genetics and pathogenesis of chronic granulomatous disease and development of new gene transfer therapeutic approaches
  • EuroGeBeta: European network on genetics, pathophysiology and translational research into rare pancreatic beta-cell insufficiency diseases
  • GETHERTHAL: Improvements of vector technology and safety for the gene therapy of thalassemia
  • HMA-IRON: Towards improved diagnosis and treatment of rare inherited microcytic hypochromic anemias related to iron metabolism
  • MLC-Teams: Megalencephalic leukoencephalopathy with subcortical cysts: from molecular basis to search for therapy
  • NEMMYOP: Functional characterization of nemaline myopathy in a murine model with nebulin mutation: moving from basic understanding towards therapeutic interventions
  • NEUTRO-NET: Inherited inhibition of inborn immunity – an integrated molecular genetic approach to discover novel human gene defects
  • NsEuroNet: European network on noonan syndrome and related disorders
  • RHORCOD: Comprehensive analysis of rod-cone photoreceptor degeneration associated with rhodopsin gene mutations